ライフサイエンスコーパス: Mycobacterium

1 We investigated a biphasic outbreak of Mycobacterium abscessus at a tertiary care hospital.

2 Multi-drug resistant Mycobacterium abscessus complex (MABSC) is a form of Non

3 Mycobacterium abscessus is a fast-growing, multidrug-res

4 terial (Mycobacterium avium complex [MAC] or Mycobacterium abscessus) disease.

5 me sequencing of a patient with disseminated Mycobacterium abscessus, Streptococcus viridians bactere

6 We used the Mycobacterium-antigen murine inflammation model and maca

7 We identified active compounds using Mycobacterium aurum.

8 chronic enteric disease in cattle caused by Mycobacterium avian subsp. paratuberculosis (MAP).

9 restored antimycobacterial activity against Mycobacterium avium and Mycobacterium bovis Bacille Calm

10 ag2(-/-)gammac(-/-) mice are as resistant to Mycobacterium avium as Rag2(-/-) mice, whereas Rag2(-/-)

11 Persistent growth of Mycobacterium avium complex (MAC) in the lungs indicates

12 ow-growing species, including members of the Mycobacterium avium complex (MAVC).

13 tory pulmonary nontuberculous mycobacterial (Mycobacterium avium complex [MAC] or Mycobacterium absce

14 One hundred isolates of Mycobacterium avium complex and eight M. simiae isolates

15 hose previously treated for tuberculosis and Mycobacterium avium complex predominated (27.7% [95% CI:

16 Mycobacterium avium subsp hominissuis is associated with

17 Available diagnostic assays for Mycobacterium avium subsp. paratuberculosis (MAP) have p

18 acillary paratuberculosis are both caused by Mycobacterium avium subspecies paratuberculosis.

19 however, even within a single subspecies of Mycobacterium avium these lipids can differ.

20 PP (Legionella spp., Legionella pneumophila, Mycobacterium avium, Mycobacterium intracellulare, Pseud

21 It was confirmed to be specific for Mycobacterium bovis and M.caprae cells.

22 ld badger population naturally infected with Mycobacterium bovis as an example.

23 ial activity against Mycobacterium avium and Mycobacterium bovis Bacille Calmette-Guerin (BCG) in vit

24 cts of an experimental iron-enriched diet on Mycobacterium bovis bacille Calmette-Guerin (BCG) infect

25 n Mycobacterium smegmatis (M. smegmatis) and Mycobacterium bovis Bacillus Calmette-Guerin (BCG).

26 genous Ag-specific CD4(+) T cells induced by Mycobacterium bovis bacillus Calmette-Guerin vaccination

27 been vaccinated with the partially effective Mycobacterium bovis BCG vaccine.

28 accine against tuberculosis, live attenuated Mycobacterium bovis BCG, has variable efficacy, but deve

29 gues exhibited balanced profiles of potency (Mycobacterium bovis BCG, M tuberculosis H37Rv), selectiv

30 , metabolome profiling in the Mtb surrogate, Mycobacterium bovis BCG, reveals significant changes in

31 Mycobacterium bovis causes tuberculosis in a wide variet

32 ty, and both the incidence and prevalence of Mycobacterium bovis show marked variation in space.

33 We applied this to cultured Mycobacterium bovis strain BCG DNA and to combined cultu

34 city of rough morphology M. tuberculosis and Mycobacterium bovis strains was greater than smooth "M.

35 lmette-Guerin (BCG), an attenuated strain of Mycobacterium bovis, is widely used as adjunctive therap

36 tantial evidence suggests that the burden of Mycobacterium bovis, the cause of bovine tuberculosis, m

37 culosis (TB) is a zoonotic disease caused by Mycobacterium bovis.

38 badgers Meles meles naturally infected with Mycobacterium bovis.

39 ycobacterium kansasii, through intermediate "Mycobacterium canettii", to the modern Mycobacterium tub

40 Mycobacterium canettii, which has a smooth colony morpho

41 Mycobacterium chimaera and other pathogens were recovere

42 tion was launched to assess risk of invasive Mycobacterium chimaera infection in cardiothoracic surge

43 The global outbreak of Mycobacterium chimaera infections associated with heater

44 Since 2013, over 100 cases of Mycobacterium chimaera prosthetic valve endocarditis and

45 in patients with disseminated infection with Mycobacterium chimaera, a slow-growing nontuberculous my

46 ambutol and pyrazinamide) was initiated upon Mycobacterium confirmation.

47 to the trehalose mycolates of representative Mycobacterium, Corynebacterium, Nocardia, and Rhodococcu

48 rved subgroup that possesses high density of Mycobacterium deaminases.

49 ted as producers of mycelial networks, while Mycobacterium gilvum VM552 served as a model polycyclic

50 sophila infected with Mycobacterium marinum, mycobacterium-induced STAT activity triggered by unpaire

51 membrane-integral adenylyl cyclase Cya from Mycobacterium intracellulare in a nucleotide-bound state

52 ental sources and patients, as well as eight Mycobacterium intracellulare isolates.

53 s salvage therapy, seven of 13 patients with Mycobacterium intracellulare lung disease had an initial

54 Legionella pneumophila, Mycobacterium avium, Mycobacterium intracellulare, Pseudmonas aeruginosa, or

55 bacilli parallels a route from environmental Mycobacterium kansasii, through intermediate "Mycobacter

56 Mycobacterium leprae causes leprosy and is unique among

57 How Mycobacterium leprae infection causes demyelination to m

58 tect leprosy and to stop the transmission of Mycobacterium leprae, the causative bacillus of the dise

59 Mycobacterium leprae, which causes leprosy, grows optima

60 d lateral flow assays (LFA) for detection of Mycobacterium leprae-specific antibodies: the visual imm

61 ng characteristics of the causative bacillus Mycobacterium leprae: the long incubation period, limite

62 We studied the earliest mycobacterium-macrophage interactions in the optically t

63 Mycobacterium tuberculosis and Mycobacterium marinum are thought to exert virulence, in

64 ation to conclude that the MMAR_0039 gene in Mycobacterium marinum is required to promote Esx-1 expor

65 regulating the levels of ESX-1 substrates in Mycobacterium marinum WhiB6 is a transcription factor th

66 alyse the initial response of neutrophils to Mycobacterium marinum, a close genetic relative of M. tu

67 In Drosophila infected with Mycobacterium marinum, mycobacterium-induced STAT activi

68 rocompartment designated the Rhodococcus and Mycobacterium microcompartment (RMM), which, along with

69 rium chimaera, a slow-growing nontuberculous mycobacterium (NTM), subsequent to cardiothoracic surger

70 (since 2012) taxonomic changes in the genus Mycobacterium Only those mycobacteria that have been iso

71 tinobacteria including members of the genera Mycobacterium, Rhodococcus, Microbacterium and Gordonia.

72 hromosome dynamics at a single-cell level in Mycobacterium smegmatis (M. smegmatis) and Mycobacterium

73 rt a 3.2 A-resolution crystal structure of a Mycobacterium smegmatis (Msm) open promoter complex (RPo

74 Overexpression of Rv3802 orthologs in Mycobacterium smegmatis and Corynebacterium glutamicum i

75 Growth of Mycobacterium smegmatis biofilms requires multiple facto

76 ported that a genetically modified strain of Mycobacterium smegmatis called IKEPLUS is a promising TB

77 Mycobacterium smegmatis contains 6 homologous mce (mamma

78 Mycobacterium smegmatis encodes four RNase H enzymes: Rn

79 ycobacteria, we executed a genetic screen in Mycobacterium smegmatis for biotin auxotrophs and identi

80 Here we report that Mycobacterium smegmatis NucS/EndoMS, a putative endonucl

81 igated, using a GFP reporter system, whether Mycobacterium smegmatis OhrR has the ability to sense an

82 trated that deletion of MSMEG_6281 (Ami1) in Mycobacterium smegmatis resulted in the formation of cel

83 lectively access mycolates on the surface of Mycobacterium smegmatis spheroplasts, allowing us to mon

84 ns in genes encoding ribosomal components in Mycobacterium smegmatis that confer resistance to severa

85 polymerase in Mycobacterium tuberculosis and Mycobacterium smegmatis that has evolved independently f

86 Escherichia coli, Staphylococcus aureus, and Mycobacterium smegmatis to quinolone antibiotics.

87 tions and their impact on gene expression in Mycobacterium smegmatis under hypochlorite stress.

88 Q TLR2 polymorphism on macrophage sensing of Mycobacterium smegmatis Upon infection with M. smegmatis

89 The enzyme Msd from Mycobacterium smegmatis was taken as a representative ca

90 ttempts to delete the NCgl2760 orthologue in Mycobacterium smegmatis were unsuccessful, consistent wi

91 suite of compounds, inhibited the growth of Mycobacterium smegmatis with an MIC80 value of 2 mug/mL.

92 sts including Mycobacterium tuberculosis and Mycobacterium smegmatis, encompass substantial genetic d

93 bacterial activity against Escherichia coli, Mycobacterium smegmatis, Staphylococcus aureus and Staph

94 source dependent in Mtb and did not occur in Mycobacterium smegmatis, suggesting that V-58-mediated g

95 exhibited impaired cell wall localization in Mycobacterium smegmatis, whereas mPDE-4A behaved similar

96 ied and characterized the MceG orthologue of Mycobacterium smegmatis.

97 bility to suppress beta-lactam resistance in Mycobacterium smegmatis.

98 says indicated that the introduction of this Mycobacterium-specific domain decreased the angular velo

99 Here, we report that a Mycobacterium-specific, 36-amino acid long C-terminal do

100 A novel endosymbiont closely related to Mycobacterium spp. was identified in Acanthamoeba polyph

101 In particular, Mycobacterium spp., very low in finished waters, occurre

102 a's Kalahari Desert have been diagnosed with Mycobacterium suricattae, a novel strain of TB, causing

103 The emergence and spread of drug-resistant Mycobacterium tuberculosis (DR-TB) are critical global h

104 Although Mycobacterium tuberculosis (M.tb) DK9897 is an attenuate

105 trans-phosphorylating phosphodiesterase from Mycobacterium tuberculosis (mPDE), that resulted in decr

106 second step in the biosynthesis of biotin in Mycobacterium tuberculosis (Mtb) and is an essential enz

107 ogens such as Staphylococcus aureus (SA) and Mycobacterium tuberculosis (Mtb) are appreciably sensiti

108 Mycobacterium tuberculosis (Mtb) can persist in the huma

109 We demonstrate that Mycobacterium tuberculosis (Mtb) causes breakdown of typ

110 ll greater than 99% of exponentially growing Mycobacterium tuberculosis (Mtb) cells, but the remainin

111 Mycobacterium tuberculosis (Mtb) characteristically caus

112 Mycobacterium tuberculosis (Mtb) contributes to the path

113 the structure and interactions of avidin and Mycobacterium tuberculosis (Mtb) CYP142A1 were assessed

114 ty, they must detect </=10 genomic copies of Mycobacterium tuberculosis (MTB) DNA, the limit of detec

115 Mycobacterium tuberculosis (Mtb) DprE1, an essential iso

116 e antibiotic with selective activity against Mycobacterium tuberculosis (Mtb) due to mechanism-based

117 e glyoxylate shunt, an essential pathway for Mycobacterium tuberculosis (Mtb) during the persistent p

118 Mycobacterium tuberculosis (Mtb) encounters stresses dur

119 Mycobacterium tuberculosis (Mtb) enters the host in aero

120 Mycobacterium tuberculosis (Mtb) expresses a broad-spect

121 The library was evaluated for inhibition of Mycobacterium tuberculosis (Mtb) growth and Mtb Antigen

122 These may restrict Mycobacterium tuberculosis (Mtb) growth, or progress to

123 Mycobacterium tuberculosis (Mtb) has a proteasome system

124 Drug discovery efforts against the pathogen Mycobacterium tuberculosis (Mtb) have been advanced thro

125 Current diagnostic tools for Mycobacterium tuberculosis (Mtb) have many disadvantages

126 imately 35000 compounds was screened against Mycobacterium tuberculosis (Mtb) in order to identify no

127 RATIONALE: How host genetic factors affect Mycobacterium tuberculosis (Mtb) infection outcomes rema

128 se antigens expressed at different stages of Mycobacterium tuberculosis (Mtb) infection, in particula

129 ositive QuantiFERON-TB test is indicative of Mycobacterium tuberculosis (Mtb) infection, which predis

130 tum-based quantitative test to detect active Mycobacterium tuberculosis (Mtb) infections in clinicall

131 Recent data indicate that the metabolism of Mycobacterium tuberculosis (Mtb) inside its host cell is

132 creted antigenic target of 6 kDa (ESAT-6) of Mycobacterium tuberculosis (Mtb) is an essential virulen

133 Mycobacterium tuberculosis (Mtb) is the causative agent

134 Mycobacterium tuberculosis (MTb) is the causative agent

135 In total, 303 randomly selected clinical Mycobacterium tuberculosis (MTB) isolates from 303 patie

136 Mycobacterium tuberculosis (Mtb) kills more humans than

137 The intracellular pathogen Mycobacterium tuberculosis (Mtb) lives within phagosomes

138 Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms an

139 Ribosomes from Mycobacterium tuberculosis (Mtb) possess species-specifi

140 al, structural and metabolomic evidence that Mycobacterium tuberculosis (Mtb) PYK uses AMP and glucos

141 rst line anti-TB drugs against intracellular Mycobacterium tuberculosis (Mtb) residing inside macroph

142 Mycobacterium tuberculosis (Mtb) scavenges lipids (chole

143 During human infection, Mycobacterium tuberculosis (Mtb) survives the normally b

144 nscriptional repressor of EthA expression in Mycobacterium tuberculosis (Mtb) that reduces the effica

145 We report that MSCs phagocytose Mycobacterium tuberculosis (Mtb) through two types of sc

146 Mycobacterium tuberculosis (Mtb) uses a complex 3', 5'-c

147 DNA polymerase DnaE1 from the major pathogen Mycobacterium tuberculosis (Mtb) uses its intrinsic PHP-

148 respiratory syndrome coronavirus (MERS-CoV), Mycobacterium tuberculosis (MTB), and human papillomavir

149 Lipomannan (LM), found on the surface of Mycobacterium tuberculosis (Mtb), is actively involved i

150 The causative pathogen, Mycobacterium tuberculosis (MTB), is estimated to have i

151 Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is the infectious dise

152 Infection with Mycobacterium tuberculosis (Mtb), the bacterium that cau

153 are critical for protective immunity against Mycobacterium tuberculosis (Mtb), the cause of tuberculo

154 Mycobacterium tuberculosis (Mtb), the etiologic agent of

155 nt, NADH:menaquinone oxidoreductase (Ndh) of Mycobacterium tuberculosis (Mtb).

156 TP) synthase as an attractive target to kill Mycobacterium tuberculosis (Mtb).

157 e results in less-effective immunity against Mycobacterium tuberculosis (Mtb).

158 ticularly in the case of multidrug-resistant Mycobacterium tuberculosis (Mtb).

159 es selective autophagy of the human pathogen Mycobacterium tuberculosis (Mtb).

160 s) and has been implicated in persistence of Mycobacterium tuberculosis (Mtb).

161 ystem capable of bacterial identification of Mycobacterium tuberculosis (TB) and Acinetobacter bauman

162 monocytogenes (rLm) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protei

163 The risk of infection with Mycobacterium tuberculosis among healthcare workers (HCW

164 cells from healthy donors were cultured with Mycobacterium tuberculosis and extracellular matrix in a

165 Mycobacterium tuberculosis and Mycobacterium marinum are

166 etween topoisomerase I and RNA polymerase in Mycobacterium tuberculosis and Mycobacterium smegmatis t

167 es that infect mycobacterial hosts including Mycobacterium tuberculosis and Mycobacterium smegmatis,

168 2Vdelta2 T cell subset is protective against Mycobacterium tuberculosis and other infections.

169 sive and sensitive WGS assay to characterize Mycobacterium tuberculosis and other M. tuberculosis com

170 Mycobacterium tuberculosis and related Corynebacterineae

171 ls) whole-genome shotgun (WGS) sequencing of Mycobacterium tuberculosis and soil micro-colonies with

172 A whole proteome screen identified Mycobacterium tuberculosis antigens associated with sero

173 While the four Mce systems of Mycobacterium tuberculosis are all energized by a single

174 Examples involving Mycobacterium tuberculosis are reviewed and analyzed wit

175 richia coli and the tripartite TAC system of Mycobacterium tuberculosis as a model to investigate how

176 us, augmenting host immune responses against Mycobacterium tuberculosis by harnessing the SET8-NQO1/T

177 Mycobacterium tuberculosis causes pulmonary tuberculosis

178 Mycobacterium tuberculosis causes tuberculosis in humans

179 detection (Nile Red staining) to interrogate Mycobacterium tuberculosis cell state.

180 last common ancestor of the rough-morphology Mycobacterium tuberculosis complex.

181 iate "Mycobacterium canettii", to the modern Mycobacterium tuberculosis complex.

182 Mycobacterium tuberculosis continues to cause devastatin

183 rasound-guided aspiration, PCR and Amplified Mycobacterium tuberculosis DNA test confirmed tubercular

184 We analyzed the influence of Mycobacterium tuberculosis drug resistance on the outcom

185 NA from infected Drosophila melanogaster and Mycobacterium tuberculosis from human blood.

186 Here we show that Rho of Mycobacterium tuberculosis functions to both define the

187 These technologies detect mutations in the Mycobacterium tuberculosis genome that confer phenotypic

188 d recombineering to identify the target of a Mycobacterium tuberculosis growth inhibitor, pointed to

189 is protection is due to direct inhibition of Mycobacterium tuberculosis growth, which prevents subseq

190 (CyC) analogs have been investigated against Mycobacterium tuberculosis H37Rv (M. tb) grown either in

191 The Mycobacterium tuberculosis H37Rv genome encodes 20 cytoc

192 lide antibiotic with potent activity against Mycobacterium tuberculosis H37Rv.

193 Mycobacterium tuberculosis has succeeded as a human path

194 toxin gene pairs, and some pathogens such as Mycobacterium tuberculosis have over 90 toxin-antitoxin

195 he virulence and persistence of M. bovis and Mycobacterium tuberculosis Here, we describe a novel fun

196 xoplasma gondii, Listeria monocytogenes, and Mycobacterium tuberculosis However, relatively little is

197 The LOD was 300 CFU of Mycobacterium tuberculosis in 1 ml sputum.

198 scherichia coli, Salmonella typhimurium, and Mycobacterium tuberculosis in human and mouse macrophage

199 stigated lactational transfer of immunity to Mycobacterium tuberculosis in MHC class I-mismatched ani

200 atest risk factor for reactivation of latent Mycobacterium tuberculosis infection (LTBI) and progress

201 cently acquired and remotely acquired latent Mycobacterium tuberculosis infection (LTBI) are clinical

202 ventions that shrink the reservoir of latent Mycobacterium tuberculosis infection (preventive therapy

203 IFN-gamma is essential for control of Mycobacterium tuberculosis infection in vitro and in viv

204 Accurate estimates of Mycobacterium tuberculosis infection in young children p

205 thylase (H4K20me1), is highly induced during Mycobacterium tuberculosis infection that orchestrates i

206 Damaging inflammation is a hallmark of Mycobacterium tuberculosis infection, and understanding

207 Tuberculosis (TB), caused by Mycobacterium tuberculosis infection, is a leading cause

208 e determined the role of IL-21R signaling in Mycobacterium tuberculosis infection, using IL-21R knock

209 platform and an in vitro macrophage model of Mycobacterium tuberculosis infection, we identified seve

210 nd conferred protection in a murine model of Mycobacterium tuberculosis infection.

211 CD4 T cells from 22 individuals with latent Mycobacterium tuberculosis infection.

212 known but rare complication associated with Mycobacterium tuberculosis infection.

213 er-individual variability in the response to Mycobacterium tuberculosis infection.

214 crucial for host resistance against chronic Mycobacterium tuberculosis infection; however, which cel

215 lity in the timing of clinical disease after Mycobacterium tuberculosis infection; incident disease c

216 synthase, is effective for the treatment of Mycobacterium tuberculosis infections that no longer res

217 ce is a major challenge for the treatment of Mycobacterium tuberculosis infections.

218 so apply our method to large-scale data from Mycobacterium tuberculosis involving ChIP-seq data on 11

219 Routine full characterization of Mycobacterium tuberculosis is culture based, taking many

220 Mycobacterium tuberculosis is known to modulate the host

221 The Rv2633c gene in Mycobacterium tuberculosis is rapidly up-regulated after

222 Mycobacterium tuberculosis is recognised as the primary

223 el method, PyroTyping, for discrimination of Mycobacterium tuberculosis isolates combining pyrosequen

224 Mycobacterium tuberculosis isolates underwent insertion

225 ci, 5 Gram-negative nonfermenting species, 9 Mycobacterium tuberculosis isolates, and 5 miscellaneous

226 Tn-Seq libraries made in isogenic strains of Mycobacterium tuberculosis lacking three different genes

227 The top Mycobacterium tuberculosis lineages represented among co

228 an be used to study host immune responses to Mycobacterium tuberculosis Mauritian cynomolgus macaques

229 Mycobacterium tuberculosis modulation of macrophage cell

230 rtant for basic mycobacterial physiology and Mycobacterium tuberculosis pathogenesis.

231 e, rhIFN-gamma reversed defective control of Mycobacterium tuberculosis proliferation by patients' ma

232 mer) reagents with subnanomolar affinity for Mycobacterium tuberculosis proteins (antigens 85A, 85B,

233 mechanisms governing neutrophil response to Mycobacterium tuberculosis remain poorly understood.

234 Mycobacterium tuberculosis remains a global threat to hu

235 Tuberculosis (TB) due to Mycobacterium tuberculosis remains a major global infect

236 The Mycobacterium tuberculosis rv2466c gene encodes an oxido

237 The Mycobacterium tuberculosis rv3802c gene encodes an essen

238 Five acquired a resistant Mycobacterium tuberculosis strain during or subsequent t

239 ng, nonreplicating persistent, and resistant Mycobacterium tuberculosis strains.

240 RATIONALE: Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associa

241 CYP121, the cytochrome P450 enzyme in Mycobacterium tuberculosis that catalyzes a single intra

242 CYP121 is a cytochrome P450 enzyme from Mycobacterium tuberculosis that catalyzes the formation

243 Mycobacterium tuberculosis that was FDA microscopy negat

244 disease that has developed sufficiently for Mycobacterium tuberculosis to be present in the airways.

245 a prototypic host-adapted airborne pathogen, Mycobacterium tuberculosis traverses the lung and has se

246 lecules targeting the cytochrome bc1 :aa3 in Mycobacterium tuberculosis triggered interest in the ter

247 nd specific identification of drug-resistant Mycobacterium tuberculosis using RPA under specific cond

248 Mycobacterium tuberculosis utilizes multiple mechanisms

249 f human behavior, host immune responses, and Mycobacterium tuberculosis virulence factors.

250 Mycobacterium tuberculosis was quantified in pretreatmen

251 lations of metabolically active and inactive Mycobacterium tuberculosis with unknown implications for

252 stion by studying the population dynamics of Mycobacterium tuberculosis within tuberculosis patients

253 Mycobacterium tuberculosis' success as a pathogen comes

254 riminately promote intracellular infections (Mycobacterium tuberculosis), and had no effect on extrac

255 isseria meningitidis, Mycoplasma pneumoniae, Mycobacterium tuberculosis, and Bartonella), and 13 viru

256 s of the spine are most frequently caused by Mycobacterium tuberculosis, and fungi.

257 d guinea pig model of aerosol infection with Mycobacterium tuberculosis, BCG and MTBVAC delivered via

258 n immunodominant and diagnostic antigen from Mycobacterium tuberculosis, in Salmonella enterica serov

259 d in vitro and intracellular potency against Mycobacterium tuberculosis, including multidrug-resistan

260 MDR-TB), caused by drug-resistant strains of Mycobacterium tuberculosis, is an increasingly serious p

261 ties and that M. smegmatis, in contrast with Mycobacterium tuberculosis, is not able to use alternati

262 elated well, showing for the first time that Mycobacterium tuberculosis, likely to be phenotypically

263 Humans serve as both host and reservoir for Mycobacterium tuberculosis, making tuberculosis a theore

264 gly, TrmD proteins from Escherichia coli and Mycobacterium tuberculosis, organisms known to synthesiz

265 ersity and resistance determinants of Indian Mycobacterium tuberculosis, particularly for the primary

266 Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major human pandem

267 ine protein kinase, is a virulence factor in Mycobacterium tuberculosis, required for inhibition of p

268 berculosis, caused by the bacterial pathogen Mycobacterium tuberculosis, requires months of antibioti

269 hylococcus aureus, Streptococcus pneumoniae, Mycobacterium tuberculosis, Salmonella enterica, Klebsie

270 The genome of Mycobacterium tuberculosis, the bacterium responsible fo

271 Slow growth of Mycobacterium tuberculosis, the causative agent of tuber

272 (F-ATP) synthase is essential for growth of Mycobacterium tuberculosis, the causative agent of tuber

273 Mycobacterium tuberculosis, the cause of Tuberculosis (T

274 s exhibit potent and selective inhibition of Mycobacterium tuberculosis, the etiological agent of TB,

275 , as well as Corynebacterium diphtheriae and Mycobacterium tuberculosis, which cause devastating huma

276 occus pneumoniae, Legionella pneumophila, or Mycobacterium tuberculosis-in a case study to show how o

277 CXCL1 and CXCL2 can significantly reduce the Mycobacterium tuberculosis-induced bioactive IL-1beta pr

278 Mycobacterium tuberculosis-induced matrix degradation wa

279 Mycobacterium tuberculosis-infected macrophages and dend

280 abundantly expressed in pulmonary lesions in Mycobacterium tuberculosis-infected nonhuman primates du

281 onducted a prospective cohort study with 834 Mycobacterium tuberculosis-infected patients from select

282 understanding of HIV-induced alterations of Mycobacterium tuberculosis-specific CD4(+) T cells that

283 There is extensive depletion of Mycobacterium tuberculosis-specific CD4+ T cells in bloo

284 hesion to type I collagen and fibronectin by Mycobacterium tuberculosis-stimulated monocytes increase

285 emergence of multidrug-resistant strains of Mycobacterium tuberculosis.

286 mycolic acids, required for the cell wall of Mycobacterium tuberculosis.

287 ions in the genomes of a pathogenic bacteria Mycobacterium tuberculosis.

288 sponse is a critical step in host control of Mycobacterium tuberculosis.

289 ive PTB, 20 (6.3%) were culture-positive for Mycobacterium tuberculosis.

290 ands of primary human macrophages exposed to Mycobacterium tuberculosis.

291 e, heat-killed Streptococcus pneumoniae, and Mycobacterium tuberculosis.

292 osome rescue process of trans-translation in Mycobacterium tuberculosis.

293 urther explored by screening 42 targets from Mycobacterium tuberculosis.

294 PI) lansoprazole to be highly active against Mycobacterium tuberculosis.

295 d time required for genetic manipulations in Mycobacterium tuberculosis.

296 ake in all representative bacteria including Mycobacterium tuberculosis; mannitol, with selective upt

297 Mycobacterium ulcerans, the causative agent of the negle

298 this goal, microbial diversity of the genus Mycobacterium was screened for clinically and environmen

299 d isoprene-degrading strains of Gordonia and Mycobacterium were characterised physiologically and the

300 Mycobacterium were identified by rpoB, sodA and hsp65 ge